Generic Name: Latanoprostene bunod
Brand Name: Vyzulta
Manufacturer: Bausch & Lomb Incorporated, a subsidiary of Valeant Canada LP
Indications: Open-angle glaucoma or ocular hypertension
Manufacturer Requested Reimbursement Criteria1:
For the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
Submission Type: New
Project Status: Pending
Call For Patient Input: October 24, 2018
Patient Input Closed: December 12, 2018
Anticipated Date: November 21, 2018
Fee Schedule: Pending
- The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of CADTH. Reimbursement criteria from CADTH will be documented in the final recommendation, if applicable.